Therapeutic RSK1 Targeting in Myelofibrosis

Abroad (travel likely)RecruitingPHASE1

Conditions

Myelofibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Washington University School of Medicine, St Louis, Missouri, United States
Contact: Study coordinator (Amy W Zhou, M.D.) · a.zhou@wustl.edu · 314-362-8814
Contact: Principal Investigator (Amy W Zhou, M.D.)
Liang Huang, M.D. (Sub-investigator)
Feng Gao, Ph.D. (Sub-investigator)

Study leads

Amy W Zhou, M.D.
Principal Investigator
Washington University School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Atlanta, United States

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Acute Myeloid Leukemia · Myelodysplastic Syndromes · Chronic Myelomonocytic Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Rochester, United States

To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects

Myelofibrosis

Abroad (travel likely)RecruitingPHASE1

Luoyang, China · Jinan, China

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis

Myelofibrosis

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Irvine, United States